UNJHA FORMULATIONS LTD. Share Price

₹ 26.56

-₹0.69 (-2.53%)
1D
Last updated 03 Nov, 2026, 14:29 IST
BSE: 531762
|
Pharmaceuticals

UNJHA FORMULATIONS LTD. Share Price Today

As of 4 Nov 2026, UNJHA FORMULATIONS LTD. share price is ₹26.56. The stock opened at ₹28.38, compared to its previous close of ₹27.25. During today's trading session, UNJHA FORMULATIONS LTD. share price moved in the range of ₹26.56 to ₹28.38, with an average price of ₹27.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹17.52 and a high of ₹36.38.

Share price over the last 1 day fell from 27.25 to 26.56, ranging between 26.56 and 28.38.

₹26.56
2.53% down today
₹28.38
1D LOW
1D HIGH

UNJHA FORMULATIONS LTD. Stock Insights

Stock Performance
OutperformingBeat Nifty by 8.78 % in last 3 month
UNJHA FORMULATIONS LTD. stock performance
Open₹28.38
High₹28.38
Low₹26.56
Prev. close₹27.25
UNJHA FORMULATIONS LTD. trading activity
Volume186
Average traded price₹27.53
Last traded time02:29:13 03 Nov
Last traded quantity18

Circuit
L
H
₹25.89
₹28.61
52-week
L
H
₹17.52
₹36.38
Mkt Cap Cr
12.21

P/E
25.95

P/B
3.18

ROA
8.71%
ROE
18.34%

ROCE
25.02%

Quick Ratio
2.15

EV/EBITDA
12.62

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Unjha Formul. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Unjha Formul. appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

UNJHA FORMULATIONS LTD. Company Background

ISIN
INE576D01015
Sector Market Cap
₹ 12.21 Cr

Unjha Formulations Limited is an India-based company, which is engaged in manufacturing and exporting of isabgol (psyllium) ayurvedic products. The Company is engaged in service to the isabgol (psyllium) ayurvedic formulation profession. It also manufactures all kinds of small volume ayurvedic isabgol (psyllium) powder and is tested at its plant with a modern and well equipped physico chemical and micro biological quality control laboratory. The Company’s Anchor Sat-Isabgol is available in 50 grams (gms), 100 gm, 200 gm, and 400 gm. Its isabgo husk formulation is available in the elaichi flavor. The Company’s Fibron is available in 100 gms and 300 gms. Its Isabgol Poder is available in the orange flavor. Its Fibron SF (sugar-free) is available in 100 gm and 300 gm.

UNJHA FORMULATIONS LTD. Financial Highlights

  • Revenue: UNJHA FORMULATIONS LTD. reported revenue of ₹15.75 crore in FY26 vs ₹13.98 crore in FY25. It showed an increase of 12.66% on a yearly basis.
  • Operating Profit: UNJHA FORMULATIONS LTD. reported an operating profit of ₹0.95 crore in FY26 vs ₹0.52 crore in FY25. It showed an increase of 82.69% on a year-on-year basis.
  • Net Profit: UNJHA FORMULATIONS LTD. reported a net profit of ₹0.70 crore in FY26 vs ₹0.41 crore in FY25. It showed an increase of 70.73% on a yearly basis.

UNJHA FORMULATIONS LTD. Quarterly Result Highlights

  • UNJHA FORMULATIONS LTD. reported revenue of ₹3.31 crore in Jun 2026, compared with ₹3.33 crore in Mar 2026, representing a decrease of 0.60% on a quarter-on-quarter (QoQ) basis.
  • UNJHA FORMULATIONS LTD. reported an operating profit of ₹0.16 crore in Jun 2026, compared with ₹0.49 crore in Mar 2026, representing an increase of 132.65% on a quarter-on-quarter (QoQ) basis.
  • UNJHA FORMULATIONS LTD. reported a profit of ₹0.16 crore in Jun 2026, compared with ₹0.74 crore in Mar 2026, reflecting an increase of 121.62% on a QoQ basis.
  • The earnings per share (EPS) of UNJHA FORMULATIONS LTD. stood at ₹1.57 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
36.93%
FII
0.00%
Other DII
0.00%
Retail and other
63.08%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

UNJHA FORMULATIONS LTD. Investment Returns

1 day
-2.53%

1 week
+2.11%

1 month
-19.52%

1 year
+13.07%

3 years
+46.66%

5 years
+151.52%

UNJHA FORMULATIONS LTD. Share Price History

UNJHA FORMULATIONS LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹28.38 / ₹26.56
-2.53%
02 Nov 26
₹29.85 / ₹27.25
-4.22%
30 Oct 26
₹26.90 / ₹28.45
+4.71%
29 Oct 26
₹27.12 / ₹27.17
+0.67%
Show more

UNJHA FORMULATIONS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹15.59₹13.86₹18.50₹13.15
Other Income₹0.16₹0.11₹0.01₹0.03
Total Revenue₹15.75₹13.98₹18.51₹13.18
Total Expenses₹14.79₹13.45₹18.06₹12.85
Profit Before Tax₹0.95₹0.52₹0.45₹0.33
Tax₹0.25₹0.12₹0.17₹0.05
Profit After Tax₹0.70₹0.41₹0.28₹0.28
EPS - Basic₹1.57₹0.91₹0.62₹0.63
EPS - Diluted₹1.57₹0.91₹0.62₹0.63

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.95₹0.52₹0.45₹0.33
Income before WC changes₹1.12₹0.60₹0.59₹0.46
Change in Assets₹0.42₹0.30-₹0.64-₹0.35
Change in Liabilities-₹0.06-₹0.80₹1.12-₹0.33
Change in WC₹0.36-₹0.50₹0.49-₹0.67
Cash flow from Operations₹1.24-₹0.04₹1.03-₹0.26
Cash flow from Investing-₹0.23-₹0.18-₹0.11-₹0.10
Cash flow from Financing-₹0.01-₹0.01-₹0.05-₹0.06
Total Cash Flow₹1.00-₹0.23₹0.86-₹0.42
Cash (Start of the year)₹0.64₹0.87₹0.01₹0.43
Cash (End of the year)₹1.64₹0.64₹0.87₹0.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1.30₹1.20₹1.12₹1.10
Current Assets₹4.21₹3.35₹3.81₹2.31
Total Assets₹5.51₹4.56₹4.93₹3.41
Current Liabilities₹1.67₹1.41₹2.20₹0.96
Net Current Asset₹2.54₹1.94₹1.62₹1.36
Non-Current Liabilities₹0.00₹0.00₹0.01₹0.00
Equity Capital₹3.84₹3.14₹2.73₹2.45
Total Equity & Liabilities₹5.51₹4.56₹4.93₹3.41
* All values are in INR Crore
UNJHA FORMULATIONS LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
1826.6400
9926.5800
101326.5600
0000
0000
Total bid quantity1,130
Total ask quantity0
UNJHA FORMULATIONS LTD. technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
37.95
Neutral

ATR (14)
1.74
Neutral

STOCH(9,6)
27.96
Neutral

STOCH RSI (14)
32
Neutral

ADX(9)
24.96
Bearish

UO(9)
32.04
Neutral

ROC(12)
-14.32
Bearish

WillR(14)
-83.09
Bullish
Period
Simple value
Exponential vaue

5D
27.28
27.21

10D
27.5
27.86

20D
29.69
28.96

50D
30.18
29.18

100D
26.78
27.51
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

UNJHA FORMULATIONS LTD.
Pharmaceuticals
Add Stock
Add Another

UNJHA FORMULATIONS LTD. Returns Calculator

UNJHA FORMULATIONS LTD. Share Price FAQs












Please be aware that UNJHA FORMULATIONS LTD. stock prices are subject to continuous fluctuations due to various factors.